Dublin, Oct. 06, 2017 -- The "Transdermal Drug Delivery - Technologies, Markets, and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering.
This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers. The most commonly used transdermal system is the skin patch using various types of technologies. Nanoparticles as well as the use of physical agents to facilitate transcutaneous drug delivery is described. Microneedle and needleless technologies are also described.
Transdermal technologies may be applied for several categories of pharmaceuticals used for the treatment of disorders of the skin or for systemic effect to treat diseases of other organs. Several transdermal products and applications include hormone replacement therapy, contraception, management of pain, angina pectoris, smoking cessation and neurological disorders such as Parkinson's disease. The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2016 to 2026. This market is analyzed according to geographical regions as well.
Benefits of this report
- Up-to-date one-stop information on transdermal drug delivery
- Description of 111 companies involved and 111 collaborations in this area
- Market analysis 2016-2026/
- Market values in major regions
- Strategies for developing markets for transdermal drug delivery
- A selected bibliography of 220 publications
- Text is supplemented by 22 tables and 15 figures
Who should read this report?
- Biotechnology companies developing transdermal technologies
- Drug delivery companies
- Pharmaceutical companies interested in transdermal drug delivery
- Pharmaceutical research institutes
Key Topics Covered:
Executive Summary
1. Basics of Transdermal Drug Delivery
2. Transdermal Drug Delivery Technologies
3. Transdermal Therapeutics
4. Markets for Transdermal Drug Delivery
5. Companies involved in transdermal drug delivery
6. References
For more information about this report visit https://www.researchandmarkets.com/research/4t744b/transdermal_drug
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Transdermal and Transmucosal Drug Delivery


FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20 



